Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

Completed

Conditions studied: Chlamydia

In brief

This is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection. This study is not driven by a hypothesis.

Key facts

Study ID

NCT00970749

Run by

University of Pittsburgh

People needed

55

Starts

2009-12-01

Expected to finish

2010-06-01

Last updated by the study team

2017-04-07

Who can join

Age: 15 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women between 15-35 years of age at the time of enrollment onto this study. Minors between the ages of 1-17 will require parental consent to participate in the study.
• History of, in past 5 years, endocervical C. trachomatis infection (total of 20 women) or no history of endocervical C. trachomatis infection (total of 10 women).

You may not qualify if…

• Pregnancy.
• Immunocompromised, by history (including but not limited to known HIV, cancer, autoimmune diseases).

Where it is running

• Magee-Womens Hospital of UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.